Skip to content
Awesome – Lifestyle
Author:
Orchestra BioMed Holdings, Inc.
Hugel reports record first-half earnings driven by strong botulinum toxin growth
August 6, 2026
Hugel Aesthetics Expands U.S. Presence with Commercial, Medical and Scientific Investments
July 22, 2026
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes
June 29, 2026
Hugel showcases global K-aesthetics momentum at AMWC KOREA
June 22, 2026
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 2, 2026
Hugel highlights global vision for K-aesthetics
May 22, 2026
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference
May 19, 2026
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
May 12, 2026
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
May 12, 2026
Hugel reports record Q1 earnings, driving strong global growth in aesthetics
May 8, 2026
←
Previous Page
1
2
3
Next Page
→